The Department of Health and Human Services awarded a $2.1 million firm-fixed-price purchase order to Life Technologies Corporation for BIOWATCH inventory. The prime contractor, Life Technologies Corporation, will provide Platinum Taq DNA Polymerase enzyme kits to support assays used by public health and BioWatch laboratories across the United States. The funding agency, HHS's Office of the Assistant Secretary for Administration, issued a special notice for sole source procurement of these kits,...
This is a $2,243,684.50 firm fixed-price purchase order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on December 23, 2024. The contract is for the delivery of PLATINUM TAQ BIOWATCH products and associated services, with a period of performance through December 31, 2026. This award does not utilize a set-aside designation. Life Technologies Corporation is the prime...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services (HHS) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract, with a ceiling value of $1,740,000.00, is for the delivery of PLATINUM TAQ DNA products. The contract does not have a set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies to government agencies and...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $23,400 firm fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the delivery of 5,000 reactions of Platinum Taq High Fidelity PCR reagents. This award was not associated with a set-aside program. Life Technologies Corporation has a history of providing scientific instruments, reagents, and services to support biomedical research, healthcare, and other...
This is a $149,538 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for the supply of Platinum Taq DNA Polymerase, a specialized reagent used in DNA analysis, to support the agency's biomedical research and healthcare missions. The original contract opportunity was a sole-source solicitation, indicating Life Technologies' proprietary technology and expertise...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price contract to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for the supply of TAQPATH 1-STEP RT-QPCR MM 5X1ML. The contract was awarded on March 18, 2020 with a completion date of March 24, 2020 and a potential value of $494,499.90. This award was not set aside. Life Technologies Corporation is a division of the parent company...
This is a Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract, valued at $22,466.85, is for the provision of custom TaqMan gene assays and synthesis kits. This contract was not set aside for any specific business category. Life Technologies Corporation has a history of serving as a prime...
The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a firm fixed price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for the delivery of BIOWATCH INVENTORY ABI7500 UNITS. The potential value of the contract is $324,840.50 with a completion date of September 30, 2021. The contract has no set-aside designation. Life Technologies Corporation is a division of the parent...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $16,859.97 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables, for the delivery of 7500 Fast Real-Time PCR Systems. This award does not have a set-aside designation. Life Technologies Corporation has a history of providing genetic analysis technologies, laboratory equipment, and technical services to support...
This $249,515.90 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables that provides products and services to support federal biomedical research, applied markets, and forensic analysis. The contract, which does not have a set-aside designation, is for the BIOWATCH INVENTORY requirement, with a completion date of February 23, 2021. Life Technologies...